5-(N-(((2R,3S,4R,5R)-5-(3-bromobenzamido)-3,4,6-trihydroxytetrahydro-2H-pyran-2-yl)methyl)sulfamoyl)-2-methylfuran-3-carboxylic acid

ID: ALA3805205

Chembl Id: CHEMBL3805205

PubChem CID: 57411679

Max Phase: Preclinical

Molecular Formula: C19H21BrN2O10S

Molecular Weight: 549.35

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1oc(S(=O)(=O)NC[C@H]2OC(O)[C@H](NC(=O)c3cccc(Br)c3)[C@@H](O)[C@@H]2O)cc1C(=O)O

Standard InChI:  InChI=1S/C19H21BrN2O10S/c1-8-11(18(26)27)6-13(31-8)33(29,30)21-7-12-15(23)16(24)14(19(28)32-12)22-17(25)9-3-2-4-10(20)5-9/h2-6,12,14-16,19,21,23-24,28H,7H2,1H3,(H,22,25)(H,26,27)/t12-,14-,15-,16-,19?/m1/s1

Standard InChI Key:  GEVMYBPXLUPCSS-VGFLMNAYSA-N

Associated Targets(Human)

HK1 Tchem Hexokinase type I (266 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HK2 Tchem Hexokinase type II (81 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 549.35Molecular Weight (Monoisotopic): 548.0100AlogP: -0.44#Rotatable Bonds: 7
Polar Surface Area: 195.63Molecular Species: ACIDHBA: 9HBD: 6
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 4.09CX Basic pKa: CX LogP: -0.19CX LogD: -3.33
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.26Np Likeness Score: -0.15

References

1. Lin H, Zeng J, Xie R, Schulz MJ, Tedesco R, Qu J, Erhard KF, Mack JF, Raha K, Rendina AR, Szewczuk LM, Kratz PM, Jurewicz AJ, Cecconie T, Martens S, McDevitt PJ, Martin JD, Chen SB, Jiang Y, Nickels L, Schwartz BJ, Smallwood A, Zhao B, Campobasso N, Qian Y, Briand J, Rominger CM, Oleykowski C, Hardwicke MA, Luengo JI..  (2016)  Discovery of a Novel 2,6-Disubstituted Glucosamine Series of Potent and Selective Hexokinase 2 Inhibitors.,  (3): [PMID:26985301] [10.1021/acsmedchemlett.5b00214]

Source